Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
Human Pathology|July 8, 2011
Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypesZoran Gatalica, Stan L Lilleberg, Federico A Monzon, et al.The American Journal of Surgical Pathology|October 23, 2013
GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumorsMarkku Miettinen, Peter A McCue, Maarit Sarlomo-Rikala, et al.Cancer Research|December 4, 2012
Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signaturesXiaoming Ju, Adam Ertel, Mathew C Casimiro, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2007
PET imaging of VPAC1 expression in experimental and spontaneous prostate cancerKaijun Zhang, Mohan R Aruva, Nylla Shanthly, et al.The American Journal of Surgical Pathology|February 28, 2015
Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumorsMarkku Miettinen, Peter A McCue, Maarit Sarlomo-Rikala, et al.Pathology, Research and Practice|December 18, 2024
Tumor infiltrating T-cells and loss of expression of SWI/SNF genes in varying stages of clear cell renal cell carcinomaAlaa S Hrizat, Ruihe Lin, Jaime Eberle-Singh, et al.Proceedings of the National Academy of Sciences of the United States of America|April 22, 2010
microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signalingZuoren Yu, Nicole E Willmarth, Jie Zhou, et al.Cancer Research|December 30, 2010
Disruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formationMichael J Powell, Mathew C Casimiro, Carlos Cordon-Cardo, et al.The Canadian Journal of Urology|March 7, 2017
Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to dateLeonard G Gomella, Mark J Mann, Ryan C Cleary, et al.Cancer Research|August 18, 2018
ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS MelanomaClaudia Capparelli, Timothy J Purwin, Shea A Heilman, et al.Pageof 5